Host: Mike Barnkob, MD. PhD. Odense University Hospital, Denmark.
Latest Episodes
Ep. 08: The future of tumor-infiltrating lymphocyte (TIL) therapy. Interview with Dr Özcan Met
Tumour-infiltrating lymphocyte (TIL) therapy have been a stable of cell therapy for many years and how recently shown clinical effect in phase III studies. How are TIL...
Ep. 07: Use of T cell receptors (TCR’s) as immunotherapy against cancer
In this episode we interview Dr. Johanna Olweus and Dr. Morten Milek Nielsen from University of Oslo about the use of T cell receptors (TCR’s) as immunotherapy against...
Ep. 06: CRISPR and its use in cellular therapies
In this episode we talk to Dr. Rasmus O Bak from Aarhus University about the use of CRISPR and its use in cellular therapies. CRISPR has now become a method to not onl...
Ep. 05: NK cells as anti-cancer medicine. Interview with Dr Arnika K. Wagner, Dr Evren Alici and Dr Sigrid Skånland
What are NK cells, how do they function and how can we utilize them as a cellular therapy? In this episode we are joined by Dr Arnika K. Wagner and Dr Evren Alici, bot...
Ep. 04: What is precision medicine? Interview with Dr Caroline Heckman and Dr Kjetil Tasken
What is precision medicine? How can cancer patients benefit from it, and what role does it play in cellular therapy? In this episode our guests Dr Caroline Heckman (Re...